BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3947208)

  • 1. Structural abnormalities in the frontal system in schizophrenia. A magnetic resonance imaging study.
    Andreasen N; Nasrallah HA; Dunn V; Olson SC; Grove WM; Ehrhardt JC; Coffman JA; Crossett JH
    Arch Gen Psychiatry; 1986 Feb; 43(2):136-44. PubMed ID: 3947208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofrontality in schizophrenia: a review of the evidence.
    Williamson P
    Can J Psychiatry; 1987 Jun; 32(5):399-404. PubMed ID: 3308053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism.
    Yacubian J; de Castro CC; Ometto M; Barbosa E; de Camargo CP; Tavares H; Cerri GG; Gattaz WF
    Schizophr Res; 2002 Dec; 58(2-3):117-22. PubMed ID: 12409151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms.
    Sanfilipo M; Lafargue T; Rusinek H; Arena L; Loneragan C; Lautin A; Feiner D; Rotrosen J; Wolkin A
    Arch Gen Psychiatry; 2000 May; 57(5):471-80. PubMed ID: 10807487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.
    Ho BC; Andreasen NC; Nopoulos P; Arndt S; Magnotta V; Flaum M
    Arch Gen Psychiatry; 2003 Jun; 60(6):585-94. PubMed ID: 12796222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in schizophrenia: specific relations to ventricular size and negative symptomatology.
    Keilp JG; Sweeney JA; Jacobsen P; Solomon C; St Louis L; Deck M; Frances A; Mann JJ
    Biol Psychiatry; 1988 May; 24(1):47-55. PubMed ID: 3370277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures.
    Gur RE; Cowell P; Turetsky BI; Gallacher F; Cannon T; Bilker W; Gur RC
    Arch Gen Psychiatry; 1998 Feb; 55(2):145-52. PubMed ID: 9477928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptoms and clinical subtype.
    Turetsky B; Cowell PE; Gur RC; Grossman RI; Shtasel DL; Gur RE
    Arch Gen Psychiatry; 1995 Dec; 52(12):1061-70. PubMed ID: 7492258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of neuropsychological deficits in familial schizophrenics, nonfamilial schizophrenics, and normal controls.
    Sautter FJ; McDermott BE; Cornwell JM; Borges A; Johnson J; Vasterling JJ; Marcontell DK
    J Nerv Ment Dis; 1997 Oct; 185(10):641-4. PubMed ID: 9345256
    [No Abstract]   [Full Text] [Related]  

  • 12. Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study.
    Kubicki M; Westin CF; Maier SE; Frumin M; Nestor PG; Salisbury DF; Kikinis R; Jolesz FA; McCarley RW; Shenton ME
    Am J Psychiatry; 2002 May; 159(5):813-20. PubMed ID: 11986136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenic syndromes and frontal lobe performance.
    Liddle PF; Morris DL
    Br J Psychiatry; 1991 Mar; 158():340-5. PubMed ID: 2036532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative symptoms and hypofrontality in chronic schizophrenia.
    Wolkin A; Sanfilipo M; Wolf AP; Angrist B; Brodie JD; Rotrosen J
    Arch Gen Psychiatry; 1992 Dec; 49(12):959-65. PubMed ID: 1360200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive dyskinesia in schizophrenia. Relationship to minor physical anomalies, frontal lobe dysfunction and cerebral structure on magnetic resonance imaging.
    Waddington JL; O'Callaghan E; Buckley P; Madigan C; Redmond O; Stack JP; Kinsella A; Larkin C; Ennis JT
    Br J Psychiatry; 1995 Jul; 167(1):41-4. PubMed ID: 7551606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study.
    Wolkin A; Choi SJ; Szilagyi S; Sanfilipo M; Rotrosen JP; Lim KO
    Am J Psychiatry; 2003 Mar; 160(3):572-4. PubMed ID: 12611842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia.
    Shioiri T; Kato T; Inubushi T; Murashita J; Takahashi S
    Psychiatry Res; 1994 Dec; 55(4):223-35. PubMed ID: 7701036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MRI findings in schizophrenic patient with frontal lobe atrophy].
    Kimura N; Inayama Y; Shigenobu K; Kakiuchi Y; Tabushi K
    Seishin Shinkeigaku Zasshi; 2004; 106(2):152-60. PubMed ID: 15052786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities.
    Andreasen NC; Ehrhardt JC; Swayze VW; Alliger RJ; Yuh WT; Cohen G; Ziebell S
    Arch Gen Psychiatry; 1990 Jan; 47(1):35-44. PubMed ID: 2294854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the neuropsychological and neuroanatomical changes that occur over the first 2-3 years of illness in patients with first-episode schizophrenia.
    Zipparo L; Whitford TJ; Redoblado Hodge MA; Lucas S; Farrow TF; Brennan J; Gomes L; Williams LM; Harris AW
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):531-8. PubMed ID: 18061326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.